Exelixis (EXEL): recent analyst upgrade, revenue strong growth and present Positive drug trial result; the stock can go much higher. currently shorters are trying to cover their short position. as its price goes further higher, potential short squeeze might happen here and the stock price will skyrocket higher.
Submitted October 10, 2016 at 02:52PM by gmike228 http://ift.tt/2ekBsBs
No comments:
Post a Comment